Antibody response in the intestinal secretions of volunteers immunized with various cholera vaccines
- PMID: 779998
- PMCID: PMC2366383
Antibody response in the intestinal secretions of volunteers immunized with various cholera vaccines
Abstract
The efficacy of various cholera vaccines in eliciting an intestinal antibody response was assessed in human volunteers who received oral live, oral killed, or parenteral cholera vaccines, or placebo. The intestinal immune response in terms of antibacterial and antitoxin antibodies was determined 2 and 4 weeks after immunization. By means of the mouse peritoneum opsonization assay and the infant mouse protection test, antibacterial activity could be detected in the intestinal secretions of volunteers who had been immunized either orally or by the parenteral route. Significant protective activity and duration of immunity were observed with the oral killed vaccine. The bacteriological data indicated the absence of significant intestinal colonization of the live attenuated strain after oral administration, and probably explains the observed lack of effectiveness of the oral vaccine compared with that of the killed vaccine. The predominant immunoglobulin class of intestinal antibody was found to be IgA. None of the vaccines used in the study elicited significant antitoxin activity in the intestinal secretions, as determined by the skin permeability neutralization test.
Similar articles
-
Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.Bull Pan Am Health Organ. 1995 Dec;29(4):312-21. Bull Pan Am Health Organ. 1995. PMID: 8605522 Clinical Trial.
-
Current status of an oral B subunit whole cell cholera vaccine.Dev Biol Stand. 1983;53:73-9. Dev Biol Stand. 1983. PMID: 6873479
-
Efficacy of a live oral cholera vaccine in human volunteers.Dev Biol Stand. 1976;33:108-12. Dev Biol Stand. 1976. PMID: 782960 Clinical Trial.
-
A review of the current status of enteric vaccines.P N G Med J. 1995 Dec;38(4):325-31. P N G Med J. 1995. PMID: 9522876 Review.
-
Live attenuated oral cholera vaccines.Expert Rev Vaccines. 2006 Aug;5(4):483-94. doi: 10.1586/14760584.5.4.483. Expert Rev Vaccines. 2006. PMID: 16989629 Review.
Cited by
-
New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.Microbiol Rev. 1983 Dec;47(4):510-50. doi: 10.1128/mr.47.4.510-550.1983. Microbiol Rev. 1983. PMID: 6363898 Free PMC article. Review.
-
Killed oral cholera vaccines: history, development and implementation challenges.Ther Adv Vaccines. 2014 Sep;2(5):123-36. doi: 10.1177/2051013614537819. Ther Adv Vaccines. 2014. PMID: 25177492 Free PMC article. Review.
-
Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.Clin Diagn Lab Immunol. 1996 Jul;3(4):451-5. doi: 10.1128/cdli.3.4.451-455.1996. Clin Diagn Lab Immunol. 1996. PMID: 8807212 Free PMC article.
-
Guinea pig lung lavage cells after intranasal BCG sensitization.Infect Immun. 1979 Sep;25(3):844-8. doi: 10.1128/iai.25.3.844-848.1979. Infect Immun. 1979. PMID: 387595 Free PMC article.
-
Scalable production and immunogenicity of a cholera conjugate vaccine.Vaccine. 2021 Nov 16;39(47):6936-6946. doi: 10.1016/j.vaccine.2021.10.005. Epub 2021 Oct 27. Vaccine. 2021. PMID: 34716040 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous